Skip to main content
AV

Avilar Therapeutics

Waltham, United States
Last funding
$15.0M
SeedFeb 2023

Avilar Therapeutics is a biopharmaceutical company focusing on extracellular protein degradation.

Backed byRA Capital ManagementSanofi VenturesMedical Excellence CapitalAstellas Venture Management

About Avilar Therapeutics

How much funding has Avilar Therapeutics raised?

Avilar Therapeutics has raised $15.0M in total funding. The most recent round was Seed. The last funding was announced in February 2023.

Who are Avilar Therapeutics's investors?

Avilar Therapeutics's investors include RA Capital Management, Sanofi Ventures, Medical Excellence Capital, Astellas Venture Management.

Where is Avilar Therapeutics headquartered?

Avilar Therapeutics is headquartered in Waltham, United States.

What does Avilar Therapeutics do?

Avilar Therapeutics is a biopharmaceutical company focusing on extracellular protein degradation.

What stage is Avilar Therapeutics at?

Avilar Therapeutics is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Avilar Therapeutics — Funding & Investors." VCBacked, February 16, 2023, https://www.vcbacked.co/company/avilar-therapeutics. Accessed November 14, 2026.
APA
VCBacked. (2023). Avilar Therapeutics — Funding & Investors. Retrieved November 14, 2026, from https://www.vcbacked.co/company/avilar-therapeutics
Wikipedia (cite web)
{{cite web |title=Avilar Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/avilar-therapeutics |website=VCBacked |access-date=November 14, 2026}}

Profile data sourced and verified per the VCbacked methodology · Last funding round dated

Work at Avilar Therapeutics? Request a listing update

Founder contacts
m***@avilar-tx.com
linkedin.com/in/●●●●●●
Emails, phones & LinkedIn · 41,000+ verified contacts
Get instant access →